Nivolumab
Product Specifications
UNSPSC Description
Nivolumab is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer.
Target Antigen
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Anti-PD-1_Neutralizing_Antibody_2.html
Purity
99.63
Solubility
H2O
Smiles
[Nivolumab]
References & Citations
[1]Wang C, et al. In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates. Cancer Immunol Res. 2014 Sep;2(9):846-56.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P9903/Nivolumab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P9903/Nivolumab-SDS-MedChemExpress.pdf
Clinical Information
Launched
CAS Number
946414-94-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ARP63219_P050-FITC 100 µL
BOK Antibody - N-terminal region: FITC (ARP63219_P050-FITC)
Ask
View Details 